Gabapentin Tablet
Product Images NDC 63629-7307

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 63629-7307). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1

A line graph depicting mean pain scores over an 8-week period for two groups: placebo and gabapentin 3600 mg/day. The x-axis represents weeks, with a 4-week dose titration period followed by a 4-week fixed dose period. The y-axis shows mean pain scores, with gabapentin group scores decreasing over time compared to placebo.*

FDA Label Image

Figure2

Line graph showing mean pain scores over 7 weeks comparing placebo and gabapentin at doses of 1800 mg/day and 2400 mg/day. The timeline includes a 3-week dose titration period followed by a 4-week fixed dose period. Pain scores decrease more in gabapentin groups than placebo over time.*

FDA Label Image

Figure3

A bar chart titled 'Proportion of Responders (patients with > 50% reduction in pain score) at Endpoint: Controlled PHN Studies' displaying data from two studies. It compares placebo (PBO) and gabapentin (GBP) at different dosages, showing percentages of responders. Study 1 compares PBO (12%) and GBP 3600 (29%). Study 2 compares PBO (14%), GBP 1800 (32%), and GBP 2400 (34%). Statistical significance is noted with p-values <0.01 and <0.001.*

FDA Label Image

Figure4

A scatter plot comparing difference percentages by daily dose (mg) from three studies labeled a, b, and c. The x-axis represents daily dose in milligrams (600 to 1800 mg), and the y-axis shows difference percentages (2 to 22%). Data points for each study are marked distinctly with black, gray, and white squares.*

FDA Label Image

Logo.jpg (Logo)

FDA Label Image

Structure.jpg (Structure)

Chemical structure of gabapentin, showing a cyclohexane ring with attached amino (H2N) and carboxyl (COOH) functional groups.*

FDA Label Image

Equation.jpg (Equation)

The image shows a formula for estimating creatinine clearance (CLCr), which includes age, weight, serum creatinine level, and a factor for female patients. It is presented as a mathematical expression to calculate renal function.*

FDA Label Image

Label Image (Lbl636297307)

Gabapentin 600 mg (CV) oral tablet label by Bryant Ranch Prepack. The label notes it is comparable to Neurontin 600 mg tablets by Glenmark Pharmaceuticals Ltd. It contains 90 tablets and includes storage instructions at 20°-25°C (68°-77°F). The National Drug Code (NDC) is 63629-7307-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.